Costa Rica Epidemiological Study on S. Pneumoniae
Continuation of the Costa Rican Epidemiologic Surveillance for Invasive Pneumococcal Disease After Introduction of the Seven Valent Vaccine Into the Universal Vaccination Program
Sponsor: Ben-Gurion University of the Negev
Suspended
Study recruitment was suspended due to lack of funding
Listed as NCT01308827, this observational or N/A phase trial focuses on Streptococcus Pneumoniae and remains suspended. Sponsored by Ben-Gurion University of the Negev, it has been updated 11 times since 2011, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Suspended
-
Sep 2024 — Sep 2025 [monthly]
Suspended
-
Jul 2024 — Sep 2024 [monthly]
Suspended
-
Dec 2021 — Jul 2024 [monthly]
Suspended
-
Jan 2021 — Dec 2021 [monthly]
Suspended
▶ Show 6 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Suspended
-
Jun 2018 — Nov 2020 [monthly]
Suspended
-
May 2018 — Jun 2018 [monthly]
Suspended
-
Apr 2018 — May 2018 [monthly]
Suspended
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Suspended NA
-
Jan 2017 — Aug 2017 [monthly]
Suspended NA
First recorded
Mar 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ben-Gurion University of the Negev
- Instituto de Atención Pediátrica
- Pfizer
For direct contact, visit the study record on ClinicalTrials.gov .